COMMUNIQUÉS West-GlobeNewswire

INVO Reports Record First Quarter 2024 Financial Results
15/05/2024
353% Revenue Growth with improvement in Adjusted EBITDA SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on [...]
Panbela Provides Business Update and Reports Q1 2024 Financial Results
15/05/2024
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today [...]
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
15/05/2024
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- [...]
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
15/05/2024
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024 Enrollment ongoing in PIVOT-PO, a pivotal Phase 3 [...]
Merit Medical Executive Leadership Team Update
15/05/2024
Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI [...]
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
15/05/2024
HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15/05/2024
Dosing of all patients in clinical trial of BT-600 has been successfully completed, with results anticipated in late Q2 2024 Clinical data on device function of the NaviCap™ platform to be presented at DDW on May 19 [...]
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15/05/2024
Topline data from Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease expected in second half of 2024 Submitted Investigational New Drug application to U.S [...]
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15/05/2024
Combination and monotherapy solid tumor dose escalation data for CLN-619 to be presented in a poster session at ASCO 2024 Annual Meeting CLN-978 development to focus exclusively on autoimmune diseases, starting with [...]
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
15/05/2024
Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of [...]
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
15/05/2024
Patient enrollment underway in sunRIZE global Phase 3 clinical study of RZ358 in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Completed in-vivo toxicology study in brown Norway [...]
Oncocyte Reports First Quarter 2024 Financial Results
15/05/2024
Conference Call on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial [...]
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
15/05/2024
— Second quarter fiscal 2024 revenue down 21.5% to $119.0 million — Year-to-date fiscal 2024 revenue down 7.2% to $254.5 million — Agreement in principle reached with the U.S. Department of Justice on related matter — [...]
AB Science reports its revenues for the year 2023 and provides an update on its activities
15/05/2024
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures [...]
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités
15/05/2024
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2023 ET LES EVENEMENTS CLEFS DE LA PERIODE Développement clinique Poursuite des procédures de demande d’autorisation [...]
60 Degrees Pharmaceuticals Announces First Quarter 2024 Results
15/05/2024
Q1 2024 net product revenues increased 515% year-over-year to $105.7 thousand. Gross profit increased from ($55.9 thousand) to $51.0 thousand. WASHINGTON, May 15, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc [...]
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
15/05/2024
DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- New research from The Cooper Institute® and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at [...]
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
15/05/2024
MOUNTAIN VIEW, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the data from its REVEALPLAQUE study, [...]
PHAXIAM provides Business and Financial Update for the First Quarter of 2024
15/05/2024
PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15, 2024, at 6.00 pm CEST Accelerated clinical efforts to roll-out PHAXIAM’s strategy in order to create a [...]

Pages